{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:55:09Z","timestamp":1788990909635,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dld.2024.05.015","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T11:14:22Z","timestamp":1717240462000},"page":"2103-2110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5698-1707","authenticated-orcid":false,"given":"Ambrin Farizah","family":"Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6373-8932","authenticated-orcid":false,"given":"Saana","family":"Palomurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"K\u00e4rj\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-0779","authenticated-orcid":false,"given":"Pirjo","family":"K\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Hanhineva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Pihlajam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-400X","authenticated-orcid":false,"given":"Ville","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.dld.2024.05.015_bib0001","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"S0168-8278","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2024.05.015_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0004","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatol Baltim Md"},{"issue":"9","key":"10.1016\/j.dld.2024.05.015_bib0006","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2024.05.015_bib0009","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jfma.2020.07.006","article-title":"Non-alcoholic fatty liver disease: a review with clinical and pathological correlation","volume":"120","author":"Chen","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0011","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European Descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2024.05.015_bib0012","doi-asserted-by":"crossref","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0013","doi-asserted-by":"crossref","first-page":"e14131","DOI":"10.1111\/ijcp.14131","article-title":"The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: a cross-sectional study","volume":"75","author":"Tutunchi","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0014","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.015_bib0015","doi-asserted-by":"crossref","unstructured":"Papatheodoridi M., Cholongitas E. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): current concepts. Curr Pharm Des 24(38):4574\u201386.","DOI":"10.2174\/1381612825666190117102111"},{"issue":"3","key":"10.1016\/j.dld.2024.05.015_bib0016","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/biom11030473","article-title":"Coupling machine learning and lipidomics as a tool to investigate metabolic dysfunction-associated fatty liver disease. A general overview","volume":"11","author":"Casta\u00f1\u00e9","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.dld.2024.05.015_bib0017","first-page":"561","article-title":"Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis","volume":"13","author":"Patel","year":"2015","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"3","key":"10.1016\/j.dld.2024.05.015_bib0018","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13679-019-00345-1","article-title":"Nonalcoholic fatty liver disease and obesity treatment","volume":"8","author":"Brunner","year":"2019","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.dld.2024.05.015_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.metabol.2019.07.002","article-title":"Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation","volume":"99","author":"Cabr\u00e9","year":"2019","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.dld.2024.05.015_bib0020","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1007\/s11695-020-04929-y","article-title":"Bariatric surgery in cirrhotic patients: a matched case-control study","volume":"30","author":"Quezada","year":"2020","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.dld.2024.05.015_bib0021","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.soard.2018.05.024","article-title":"Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): an external validation and application of a clinical NASH score","volume":"14","author":"Tan","year":"2018","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0022","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1038\/s41598-022-10481-9","article-title":"Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool","volume":"12","author":"Babu","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.dld.2024.05.015_bib0023","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.dld.2024.05.015_bib0024","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-018-0126-3","article-title":"Microbiome metabolomics reveals new drivers of human liver steatosis","volume":"24","author":"Delzenne","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.dld.2024.05.015_bib0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12072-013-9446-z","article-title":"Current histological classification of NAFLD: strength and limitations","volume":"7","author":"Bedossa","year":"2013","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.dld.2024.05.015_bib0026","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1194\/jlr.P054387","article-title":"Lipoprotein subclass metabolism in nonalcoholic steatohepatitis","volume":"55","author":"M\u00e4nnist\u00f6","year":"2014","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0027","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jhep.2019.12.008","article-title":"Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease","volume":"72","author":"Nascimbeni","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0028","first-page":"754","article-title":"Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids","volume":"41","author":"de Mello","year":"2021","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0029","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/metabo10040135","article-title":"notame\u201d: workflow for Non-targeted LC-MS metabolic profiling","volume":"10","author":"Kl\u00e5vus","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.dld.2024.05.015_bib0031","unstructured":"Re3data.Org. LIPID MAPS Lipidomics Gateway. 2017;over 43,000 entries."},{"issue":"Database issue","key":"10.1016\/j.dld.2024.05.015_bib0032","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0033","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","article-title":"METLIN: a metabolite mass spectral database","volume":"27","author":"Smith","year":"2005","journal-title":"Ther Drug Monit"},{"issue":"16","key":"10.1016\/j.dld.2024.05.015_bib0034","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1021\/acs.analchem.6b00770","article-title":"Hydrogen Rearrangement rules: computational MS\/MS fragmentation and structure elucidation using MS-FINDER software","volume":"88","author":"Tsugawa","year":"2016","journal-title":"Anal Chem"},{"issue":"11","key":"10.1016\/j.dld.2024.05.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: an R package for \u2018omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PLOS Comput Biol"},{"issue":"2","key":"10.1016\/j.dld.2024.05.015_bib0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, associates with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.015_bib0037","article-title":"The mechanism underlying the influence of indole-3-propionic acid: a relevance to metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0038","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/metabo12060514","article-title":"Interactions between tryptophan metabolism, the gut Microbiome and the immune system as potential drivers of non-alcoholic Fatty Liver Disease (NAFLD) and metabolic diseases","volume":"12","author":"Teunis","year":"2022","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0039","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jvs.2017.09.029","article-title":"Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes","volume":"68","author":"Cason","year":"2018","journal-title":"J Vasc Surg"},{"issue":"10","key":"10.1016\/j.dld.2024.05.015_bib0040","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/nu13103509","article-title":"Indole-3-propionic acid, a gut-derived tryptophan metabolite, associates with hepatic fibrosis","volume":"13","author":"Sehgal","year":"2021","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.dld.2024.05.015_bib0041","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00018-017-2504-2","article-title":"Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases","volume":"74","author":"Song","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.dld.2024.05.015_bib0042","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12035-013-8497-4","article-title":"Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways","volume":"48","author":"Oxenkrug","year":"2013","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10.1016\/j.dld.2024.05.015_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp Mol Med"},{"issue":"8","key":"10.1016\/j.dld.2024.05.015_bib0044","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.3390\/nu13082592","article-title":"Physiological functions of threonine in animals: beyond nutrition metabolism","volume":"13","author":"Tang","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0045","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/nu12051450","article-title":"Changed amino acids in NAFLD and liver fibrosis: a large cross-sectional study without influence of insulin resistance","volume":"12","author":"Hasegawa","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0046","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.dld.2024.05.015_bib0047","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1021\/acs.jafc.0c01023","article-title":"Threonine, but not lysine and methionine, reduces fat accumulation by regulating lipid metabolism in obese mice","volume":"68","author":"Ma","year":"2020","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.dld.2024.05.015_bib0048","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fgene.2019.00710","article-title":"Transcriptome analysis reveals differential expression of genes regulating hepatic triglyceride metabolism in Pekin ducks during dietary threonine deficiency","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Genet"},{"issue":"13","key":"10.1016\/j.dld.2024.05.015_bib0049","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3390\/ijms22136969","article-title":"Fructose and the Liver","volume":"22","author":"Muriel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2024.05.015_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101070","article-title":"Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase","volume":"21","author":"Battelli","year":"2019","journal-title":"Redox Biol"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0051","doi-asserted-by":"crossref","first-page":"F727","DOI":"10.1152\/ajprenal.00485.2012","article-title":"Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats","volume":"304","author":"Tapia","year":"2013","journal-title":"Am J Physiol - Ren Physiol"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0052","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0053","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0054","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.dld.2024.05.015_bib0056","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1021\/pr200629p","article-title":"A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations","volume":"10","author":"Garc\u00eda-Ca\u00f1averas","year":"2011","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0057","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.dld.2024.05.015_bib0058","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr Diabetes"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0059","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0060","article-title":"Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease","volume":"4","author":"McGlinchey","year":"2022","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.015_bib0061","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.hbpd.2021.05.008","article-title":"LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver","volume":"20","author":"Wang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0062","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.22955","article-title":"Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent","volume":"50","author":"Chamulitrat","year":"2009","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0063","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00216-020-02996-9","article-title":"Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry","volume":"413","author":"Yamamoto","year":"2021","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0064","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.dld.2024.05.015_bib0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.dld.2024.05.015_bib0066","doi-asserted-by":"crossref","DOI":"10.21037\/hbsn.2019.10.35","article-title":"PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver","volume":"9","author":"Yuan","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"16","key":"10.1016\/j.dld.2024.05.015_bib0067","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127902","article-title":"Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids","volume":"4","author":"Luukkonen","year":"2019","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.dld.2024.05.015_bib0068","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2024.05.015_bib0069","first-page":"523","article-title":"Phosphatidylcholine and the CDP\u2013choline cycle","volume":"1831","author":"Fagone","year":"2013","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"10.1016\/j.dld.2024.05.015_bib0070","unstructured":"A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes | Nat Commun [Internet]. [cited 2023 Jan 22];Available from: https:\/\/www.nature.com\/articles\/s41467-022-35158-9."},{"issue":"2","key":"10.1016\/j.dld.2024.05.015_bib0071","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0072","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dld.2024.05.015_bib0073","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin Immunol"},{"issue":"4","key":"10.1016\/j.dld.2024.05.015_bib0074","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2016.12.020","article-title":"PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease","volume":"152","author":"Simons","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2024.05.015_bib0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00217-014-2359-9","article-title":"Impact of a 6-week very low-calorie diet and weight reduction on the serum and fecal metabolome of overweight subjects","volume":"240","author":"Schmedes","year":"2015","journal-title":"Eur Food Res Technol"},{"issue":"6","key":"10.1016\/j.dld.2024.05.015_bib0076","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1381\/096089206777346682","article-title":"Change in liver size and fat content after treatment with Optifast very low calorie diet","volume":"16","author":"Lewis","year":"2006","journal-title":"Obes Surg"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T09:10:11Z","timestamp":1732525811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1590865824007734"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.015","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}